KIM DENNIS D 4
4 · CymaBay Therapeutics, Inc. · Filed May 17, 2021
Insider Transaction Report
Form 4
KIM DENNIS D
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-05-17+390,000→ 390,000 totalExercise: $4.37Exp: 2031-05-16→ Common Stock (390,000 underlying) - Award
Employee Stock Option (right to buy)
2021-05-17+10,000→ 10,000 totalExercise: $4.37Exp: 2031-05-16→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.